بدائل البحث:
changes decrease » larger decrease (توسيع البحث), change increases (توسيع البحث)
largest decrease » largest decreases (توسيع البحث), larger decrease (توسيع البحث), marked decrease (توسيع البحث)
ejection » injection (توسيع البحث)
changes decrease » larger decrease (توسيع البحث), change increases (توسيع البحث)
largest decrease » largest decreases (توسيع البحث), larger decrease (توسيع البحث), marked decrease (توسيع البحث)
ejection » injection (توسيع البحث)
-
21
-
22
-
23
-
24
-
25
-
26
Change of proportions between phases and statistical test results (corresponding to Figs 2–4).
منشور في 2022الموضوعات: -
27
-
28
-
29
-
30
Species1 from Tropical mammal functional diversity increases with productivity but decreases with anthropogenic disturbance
منشور في 2021"…Mammal community functional dispersion increased with primary productivity, while functional richness decreased with human-induced local extinctions and was significantly lower in Madagascar than other tropical regions. …"
-
31
-
32
-
33
Serial changes of urinary 8-OHdG, L-FABP, osmolality and creatinine levels at weeks 12 and 24.
منشور في 2022الموضوعات: -
34
Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
منشور في 2021"…<br></p><p><br></p><p></p><p><b>Abstract </b>Dapagliflozin [Farxiga<sup>®</sup> (USA); Forxiga<sup>® </sup>(EU)], a sodium-glucose cotransporter 2 (SGLT2) inhibitor, was recently approved in the USA and the EU for the treatment of adults with symptomatic heart failure with reduced ejection fraction (HFrEF). The cardiovascular (CV) benefits of dapagliflozin were first observed in the DECLARE-TIMI 58 trial, in which dapagliflozin 10 mg/day significantly reduced the risk of CV death or hospitalization for HF in patients with type 2 diabetes mellitus (T2DM) who had or were at risk for atherosclerotic CV disease. …"
-
35
Vericiguat: A Review in Chronic Heart Failure with Reduced Ejection Fraction
منشور في 2022"…<br> </p> <p><br></p> <p>Abstract</p> <p>Vericiguat (Verquvo<sup>®</sup>) is the first oral soluble guanylate cyclase (sGC) stimulator to be approved for the treatment of adults with symptomatic, chronic heart failure with reduced ejection fraction (HFrEF). In the phase III VICTORIA trial, vericiguat added to standard of care (SOC) was associated with a significantly lower risk of the primary composite endpoint of death from cardiovascular (CV) causes or first hospitalization from heart failure (HHF) than placebo added to SOC in adults with chronic HFrEF. …"
-
36
Cost-of-illness of heart failure with preserved and reduced ejection fraction in the Philippines
منشور في 2025"…</p> <p>The study utilized a bottom-up micro-costing approach to determine the economic burden of heart failure with mildly reduced ejection fraction (HFmrEF)/heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF) across all NYHA classifications using a societal perspective. …"
-
37
-
38
-
39
Change in rectal temperature following pre-medication, induction and inhalant anesthesia.
منشور في 2025الموضوعات: -
40